Micrornas As Modulators of Smoking-Induced Gene Expression Changes in Human Airway Epithelium

Total Page:16

File Type:pdf, Size:1020Kb

Micrornas As Modulators of Smoking-Induced Gene Expression Changes in Human Airway Epithelium MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium Frank Schembria,1, Sriram Sridharb,1, Catalina Perdomoc, Adam M. Gustafsond, Xiaoling Zhangd, Ayla Ergune, Jining Lua, Gang Liua, Xiaohui Zhanga, Jessica Bowersf, Cyrus Vazirib, Kristen Ottc, Kelly Sensingerf, James J. Collinse, Jerome S. Brodya, Robert Gettsf, Marc E. Lenburga,b,d, and Avrum Spiraa,b,d,2 aPulmonary Center, bDepartment of Pathology and Laboratory Medicine, and cGenetics and Genomics Graduate Program, Boston University School of Medicine, Boston, MA 02118; dBioinformatics Program, Boston University School of Engineering, Boston, MA 02215; eDepartment of Biomedical Engineering and Center for BioDynamics and Howard Hughes Medical Institute, Boston University, Boston, MA 02215; and fGenisphere, Inc., Hatfield, PA 19440 Edited by Charles R. Cantor, Sequenom Inc., San Diego, CA, and approved November 21, 2008 (received for review July 3, 2008) We have shown that smoking impacts bronchial airway gene Hundreds of human miRNAs have been cloned (11), with each of expression and that heterogeneity in this response associates with them predicted to regulate hundreds of genes by complementary smoking-related disease risk. In this study, we sought to determine binding to the 3Ј-untranslated region (UTR) of target mRNAs (12). whether microRNAs (miRNAs) play a role in regulating the airway A number of miRNAs have been shown to play important roles in gene expression response to smoking. We examined whole-ge- developmental timing, cell death, carcinogenesis, and stress responses in nome miRNA and mRNA expression in bronchial airway epithelium vitro (13–16), such as hypoxia (17). Whereas miRNA expression has and found 28 miRNAs to been examined in lung tumors (18–24), neither the expression of (20 ؍ from current and never smokers (n be differentially expressed (P < 0.05) with the majority being miRNA in bronchial epithelium nor the effect of smoking on bronchial down-regulated in smokers. We further identified a number of airway miRNA expression has been characterized, and it is unclear mRNAs whose expression level is highly inversely correlated with what role miRNAs play in regulating the physiological response to miRNA expression in vivo. Many of these mRNAs contain potential environmental exposures such as tobacco smoke. binding sites for the differentially expressed miRNAs in their In this study, we have profiled the miRNAs expressed in a 3؅-untranslated region (UTR) and are themselves affected by smok- relatively pure population of bronchial airway epithelial cells and ing. We found that either increasing or decreasing the levels of identified those that are differentially expressed with smoking. MEDICAL SCIENCES mir-218 (a miRNA that is strongly affected by smoking) in both Additionally, by whole-genome profiling of both miRNA and primary bronchial epithelial cells and H1299 cells was sufficient to mRNA from the same in vivo samples, we have identified mRNAs cause a corresponding decrease or increase in the expression of that are potentially regulated by smoking-induced changes in predicted mir-218 mRNA targets, respectively. Further, mir-218 miRNA expression. Through in vitro transfection experiments, we expression is reduced in primary bronchial epithelium exposed to have shown that modulating the expression of one such miRNA cigarette smoke condensate (CSC), and alteration of mir-218 levels (mir-218) is sufficient to alter the expression of a subset of the in these cells diminishes the induction of the predicted mir-218 mRNAs that are both predicted targets of this miRNA and altered target MAFG in response to CSC. These data indicate that mir-218 by smoking in vivo. Further, we have shown that cigarette smoke levels modulate the airway epithelial gene expression response to condensate (CSC) suppresses the expression of mir-218 in primary cigarette smoke and support a role for miRNAs in regulating host bronchial epithelial cells and that altering the levels of mir-218 in response to environmental toxins. these cells attenuates the CSC-dependent induction of mir-218 target mRNAs. These studies suggest that smoking-dependent cigarette smoke ͉ mir-218 ͉ bronchial airway epithelium changes in miRNA expression levels mediate some of the smoking- induced gene expression changes in airway epithelium and that pproximately 1.3 billion people smoke cigarettes worldwide, miRNAs might therefore play a role in the host response to Awhich contributes to 5 million preventable deaths per year (1). environmental exposures and the pathogenesis of smoking-related Smoking is a significant risk factor for lung cancer (2), the leading lung disease. cause of cancer-related death in the United States, and chronic Results obstructive pulmonary disease (COPD), the fourth leading cause of death worldwide. Cigarette smoking has been found to induce a Smoking Affects Expression of miRNAs in Bronchial Epithelium. Mi- number of genetic and molecular changes in the respiratory tract, croRNA and mRNA expression levels in bronchial epithelial RNA including cellular atypia (3), loss of heterozygosity (4, 5), and collected from 20 volunteers (10 current smokers, 10 never smok- promoter hypermethylation (6), which can occur in cytologically ers) recruited for this study were determined by using microarrays normal airway epithelium (5, 7). We have characterized the effects [supporting information (SI) Fig. S1]. Demographic data for these of smoking on the human airway epithelial transcriptome and found subjects are presented in Table 1. After miRNA microarray data that smoking induces expression of airway genes involved in reg- preprocessing (Fig. S2A), 232 miRNAs were detected above back- ulation of oxidant stress, xenobiotic metabolism, and oncogenesis while suppressing those involved in regulation of inflammation and Author contributions: F.S., S.S., J.L., J.J.C., J.S.B., R.G., M.E.L., and A.S. designed research; tumor suppression (8). In addition, we have described a pattern of F.S., S.S., C.P., G.L., Xiaohui Zhang, J.B., K.O., K.S., and A.S. performed research; A.M.G., J.B., gene expression in cytologically normal large airway epithelial cells C.V., K.S., and R.G. contributed new reagents/analytic tools; F.S., S.S., C.P., A.M.G., Xiaoling that can serve as a biomarker for lung cancer elsewhere in the lung Zhang, A.E., M.E.L., and A.S. analyzed data; and F.S., S.S., M.E.L., and A.S. wrote the paper. (9). These studies suggest that gene expression changes in airway The authors declare no conflict of interest. epithelium reflect host response to and damage from cigarette This article is a PNAS Direct Submission. smoke; however, the regulatory mechanisms mediating these gene 1F.S. and S.S. contributed equally to this work. expression changes are unclear. 2To whom correspondence should be addressed at: Boston University, 715 Albany Street, MicroRNAs (miRNA) are small noncoding RNAs that serve to R304, Boston, MA 02118. E-mail: [email protected]. down-regulate gene expression by suppression of translation or This article contains supporting information online at www.pnas.org/cgi/content/full/ messenger RNA (mRNA) degradation. Thirty percent of protein- 0806383106/DCSupplemental. coding genes are predicted to be regulated by miRNAs (10). © 2009 by The National Academy of Sciences of the USA www.pnas.org͞cgi͞doi͞10.1073͞pnas.0806383106 PNAS Early Edition ͉ 1of6 Downloaded by guest on October 2, 2021 Table 1. Patient demographics A Smokers (Array) Smokers (PCR) * p < 0.05 ** p < 0.01 Current smokers Never smokers P value Non smokers (Array) Non smokers (PCR) n 10 10 6 ** 14 Age 37.2 Ϯ 9.9 31.2 Ϯ 10 0.20 5 12 ** ** Race 5 AFA, 4 HIS, 1 CAU 3 AFA, 2 HIS, 5 CAU 0.15 10 4 ** Sex 7 M, 3 F 3 M, 7 F 0.07 8 3 Ϯ 6 Pack years 18.8 16 0 0.0002 2 4 1 Demographics for individuals recruited for bronchoscopy are listed above. 2 Relative Expression P values for sex (M, male; F, female) and race (AFA, African-American; HIS, Relative Expression 0 0 mir-218 mir-128b Hispanic; CAU, Caucasian) were calculated by using Fisher’s exact test. Stan- (n = 8, 4 smokers v. 4 non smokers) (n = 6, 3 smokers v. 3 non smokers) dard deviations for age and pack years are listed. P values for age and pack years were calculated by using Student’s t test. 6 ** 10 5 9 * 8 4 7 ground and the expression of these miRNAs was analyzed further. 6 3 Temporal (3 months) and technical replicates run on miRNA * 5 2 4 arrays were highly reproducible across these 232 detected miRNAs, 3 * 1 2 Relative Expression 2 Relative Expression with the temporal replicates having an R ϭ 0.91 and technical 1 0 2 0 replicates having an R ϭ 0.94. Principal component analysis of all mir-181d mir-500 232 detected miRNAs demonstrates modest separation of subjects (n = 7, 4 smokers v. 3 non smokers) (n = 7, 3 smokers v. 4 non smokers) by smoking status (Fig. S3), suggesting that smoking impacts miRNA expression in bronchial epithelium. Using a Welch’s t test, B 1.40 28 miRNAs were found to be differentially expressed between 1.20 current and never smokers (P Ͻ 0.05), which is Ϸ3 times more than 1.00 Untreated (n=4) is expected by chance at that threshold (Fig. 1, Table S1). Of these 0.80 DMSO-treated (n=6) 28 miRNAs, 23 were down-regulated in smokers. The most signif- 0.60 ϭ ϫ Ϫ4 CSC-treated (n=5) icantly altered miRNA was mir-218 (P 5 10 ), which was 0.40 down-regulated 4-fold in smokers. Four of the top differentially Relative Expression 0.20 expressed miRNAs (mir-218, mir-128b, mir-500, and mir-181d) 0.00 were validated in a subset of bronchial samples by using quantitative (q)RT-PCR (Fig.
Recommended publications
  • Lncrna MAFG-AS1 Promotes the Aggressiveness of Breast Carcinoma Through Regulating Mir-339-5P/MMP15
    European Review for Medical and Pharmacological Sciences 2019; 23: 2838-2846 LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15 H. LI1, G.-Y. ZHANG2, C.-H. PAN3, X.-Y. ZHANG1, X.-Y. SU4 1Department of Obstetrics and Gynecology, Shandong Jiyang Public Hospital, Ji’nan, Shandong, China 2Department of Anesthesiology, Shandong Jiyang Public Hospital, Ji’nan, Shandong, China 3Department of Obstetrics and Gynecology, LanCun central hospital, Jimo, Shandong, China 4Department of Critical Care Medicine, Tai’an Central Hospital, Tai’an, Shandong, China Abstract. – OBJECTIVE: The main purposes of and is the leading cause of cancer-related deaths this study are to investigate the possible effects worldwide1. Recently, treatment strategies, such of long noncoding RNAs (lncRNAs) MAFG-AS1 on as chemotherapy, radiotherapy and molecular tar- the growth and metastasis of breast carcinoma. PATIENTS AND METHODS: geting treatment significantly improve the thera- The quantitative 2 Real Time-Polymerase Chain Reaction (qRT- peutic outcome of patients . However, the clinical PCR) assay was used to assess the MAFG-AS1 outcome of patients with breast cancer needs to level in breast cancer tissues and cells. The improve. The metastasis of cancer cells is one ma- wound healing and transwell invasion analy- jor difficulty of overcoming the poor prognosis of sis were applied to explore the invasion and mi- breast cancer patients. The epithelial-mesenchy- gration of breast cancer cell in vitro. The ex- mal transition (EMT) process of cancer cells is a pressions of epithelial-mesenchymal transition 3,4 (EMT) related markers were determined by West- crucial step during metastasis .
    [Show full text]
  • C/EBP Creates Elite Cells for Ipsc Reprogramming by Upregulating
    ARTICLES C/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4 Bruno Di Stefano1,2,8,9,10, Samuel Collombet3,8, Janus Schou Jakobsen4,5,6,8, Michael Wierer7, Jose Luis Sardina1,2, Andreas Lackner1,2,9, Ralph Stadhouders1,2, Carolina Segura-Morales1,2, Mirko Francesconi1,2, Francesco Limone1,2, Matthias Mann7, Bo Porse4,5,6, Denis Thieffry3 and Thomas Graf1,2,10 Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) is typically inefficient and has been explained by elite-cell and stochastic models. We recently reported that B cells exposed to a pulse of C/EBPα (Bα0 cells) behave as elite cells, in that they can be rapidly and efficiently reprogrammed into iPSCs by the Yamanaka factors OSKM. Here we show that C/EBPα post-transcriptionally increases the abundance of several hundred proteins, including Lsd1, Hdac1, Brd4, Med1 and Cdk9, components of chromatin-modifying complexes present at super-enhancers. Lsd1 was found to be required for B cell gene silencing and Brd4 for the activation of the pluripotency program. C/EBPα also promotes chromatin accessibility in pluripotent cells and upregulates Klf4 by binding to two haematopoietic enhancers. Bα0 cells share many properties with granulocyte/macrophage progenitors, naturally occurring elite cells that are obligate targets for leukaemic transformation, whose formation strictly requires C/EBPα. The ability to reprogram somatic into pluripotent cells has revolu- complex process, where multiple players synergistically establish new tionized stem cell research with major implications for almost all transcriptional networks and remove epigenetic barriers14. Among the fields of modern biology.
    [Show full text]
  • Picosecond-Hetero-FRET Microscopy to Probe Protein-Protein Interactions in Live Cells
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector 3570 Biophysical Journal Volume 83 December 2002 3570–3577 Picosecond-Hetero-FRET Microscopy to Probe Protein-Protein Interactions in Live Cells Marc Tramier,* Isabelle Gautier,* Tristan Piolot,† Sylvie Ravalet,‡ Klaus Kemnitz,† Jacques Coppey,* Christiane Durieux,* Vincent Mignotte,‡ and Maı¨te´ Coppey-Moisan* *Institut Jacques Monod, UMR 7592, CNRS, Universite´s P6/P7, 75251 Paris Cedex 05, France; †EuroPhoton GmbH, D-12247, Berlin, Germany; and ‡ICGM, Department of Hematology, Maternite´ Port-Royal, 75014 Paris, France ABSTRACT By using a novel time- and space-correlated single-photon counting detector, we show that fluorescence resonance energy transfer (FRET) between cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) fused to herpes simplex virus thymidine kinase (TK) monomers can be used to reveal homodimerization of TK in the nucleus and cytoplasm of live cells. However, the quantification of energy transfer was limited by the intrinsic biexponential fluorescence decay of the donor CFP (lifetimes of 1.3 Ϯ 0.2 ns and 3.8 Ϯ 0.4 ns) and by the possibility of homodimer formation between two TK-CFP. In contrast, the heterodimerization of the transcriptional factor NF-E2 in the nucleus of live cells was quantified from the analysis of the fluorescence decays of GFP in terms of 1) FRET efficiency between GFP and DsRed chromophores fused to p45 and MafG, respectively, the two subunits of NF-E2 (which corresponds to an interchromophoric distance of 39 Ϯ 1 Å); and 2) fractions of GFP-p45 bound to DsRed-MafG (constant in the nucleus, varying in the range of 20% to 70% from cell to cell).
    [Show full text]
  • Expression Profiling of KLF4
    Expression Profiling of KLF4 AJCR0000006 Supplemental Data Figure S1. Snapshot of enriched gene sets identified by GSEA in Klf4-null MEFs. Figure S2. Snapshot of enriched gene sets identified by GSEA in wild type MEFs. 98 Am J Cancer Res 2011;1(1):85-97 Table S1: Functional Annotation Clustering of Genes Up-Regulated in Klf4 -Null MEFs ILLUMINA_ID Gene Symbol Gene Name (Description) P -value Fold-Change Cell Cycle 8.00E-03 ILMN_1217331 Mcm6 MINICHROMOSOME MAINTENANCE DEFICIENT 6 40.36 ILMN_2723931 E2f6 E2F TRANSCRIPTION FACTOR 6 26.8 ILMN_2724570 Mapk12 MITOGEN-ACTIVATED PROTEIN KINASE 12 22.19 ILMN_1218470 Cdk2 CYCLIN-DEPENDENT KINASE 2 9.32 ILMN_1234909 Tipin TIMELESS INTERACTING PROTEIN 5.3 ILMN_1212692 Mapk13 SAPK/ERK/KINASE 4 4.96 ILMN_2666690 Cul7 CULLIN 7 2.23 ILMN_2681776 Mapk6 MITOGEN ACTIVATED PROTEIN KINASE 4 2.11 ILMN_2652909 Ddit3 DNA-DAMAGE INDUCIBLE TRANSCRIPT 3 2.07 ILMN_2742152 Gadd45a GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 ALPHA 1.92 ILMN_1212787 Pttg1 PITUITARY TUMOR-TRANSFORMING 1 1.8 ILMN_1216721 Cdk5 CYCLIN-DEPENDENT KINASE 5 1.78 ILMN_1227009 Gas2l1 GROWTH ARREST-SPECIFIC 2 LIKE 1 1.74 ILMN_2663009 Rassf5 RAS ASSOCIATION (RALGDS/AF-6) DOMAIN FAMILY 5 1.64 ILMN_1220454 Anapc13 ANAPHASE PROMOTING COMPLEX SUBUNIT 13 1.61 ILMN_1216213 Incenp INNER CENTROMERE PROTEIN 1.56 ILMN_1256301 Rcc2 REGULATOR OF CHROMOSOME CONDENSATION 2 1.53 Extracellular Matrix 5.80E-06 ILMN_2735184 Col18a1 PROCOLLAGEN, TYPE XVIII, ALPHA 1 51.5 ILMN_1223997 Crtap CARTILAGE ASSOCIATED PROTEIN 32.74 ILMN_2753809 Mmp3 MATRIX METALLOPEPTIDASE
    [Show full text]
  • Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor Suppressors
    cancers Review Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor Suppressors Akira Kobayashi 1,2 1 Laboratory for Genetic Code, Graduate School of Life and Medical Sciences, Doshisha University, Kyotanabe, Kyoto 610-0394, Japan; [email protected]; Tel.: +81-774-65-6273 2 Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Kyoto 610-0394, Japan Received: 1 September 2020; Accepted: 17 September 2020; Published: 20 September 2020 Simple Summary: This review summarizes recent advances in our understanding of the physiological roles of the NFE2-related factor 2 (NRF2)-related transcription factor NRF3 in cancer. NRF3 confers cells with six so-called “hallmarks of cancer” through upregulating gene expression of specific target genes, leading to tumorigenesis and cancer malignancy. These driver gene-like functions of NRF3 in cancer are distinct from those of NRF2. Abstract: The physiological roles of the NRF2-related transcription factor NRF3 (NFE2L3) have remained unknown for decades. The remarkable development of human cancer genome databases has led to strong suggestions that NRF3 has functional significance in cancer; specifically,high NRF3 mRNA levels are induced in many cancer types, such as colorectal cancer and pancreatic adenocarcinoma, and are associated with poor prognosis. On the basis of this information, the involvement of NRF3 in tumorigenesis and cancer malignancy has been recently proposed. NRF3 confers cancer cells with selective growth advantages by enhancing 20S proteasome assembly through induction of the chaperone gene proteasome maturation protein (POMP) and consequently promoting degradation of the tumor suppressors p53 and retinoblastoma (Rb) in a ubiquitin-independent manner.
    [Show full text]
  • NFE2L1 Antibody Cat
    NFE2L1 Antibody Cat. No.: 31-335 NFE2L1 Antibody Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human, Mouse, Rat Antibody produced in rabbits immunized with a synthetic peptide corresponding a region IMMUNOGEN: of human NFE2L1. TESTED APPLICATIONS: ELISA, WB NFE2L1 antibody can be used for detection of NFE2L1 by ELISA at 1:7862500. NFE2L1 APPLICATIONS: antibody can be used for detection of NFE2L1 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000. POSITIVE CONTROL: 1) Cat. No. 1205 - Jurkat Cell Lysate PREDICTED MOLECULAR 85 kDa WEIGHT: Properties PURIFICATION: Antibody is purified by peptide affinity chromatography method. CLONALITY: Polyclonal CONJUGATE: Unconjugated PHYSICAL STATE: Liquid September 27, 2021 1 https://www.prosci-inc.com/nfe2l1-antibody-31-335.html Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% BUFFER: sucrose. CONCENTRATION: batch dependent For short periods of storage (days) store at 4˚C. For longer periods of storage, store STORAGE CONDITIONS: NFE2L1 antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles. Additional Info OFFICIAL SYMBOL: NFE2L1 ALTERNATE NAMES: NFE2L1, FLJ00380, LCR-F1, NRF1, TCF11 ACCESSION NO.: NP_003195 PROTEIN GI NO.: 4505379 GENE ID: 4779 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References NFE2L1 activates erythroid-specific, globin gene expression. This gene encodes a protein that is involved in globin gene expression in erythrocytes. Confusion has occurred in bibliographic databases due to the shared symbol of NRF1 for this gene, NFE2L1, and for BACKGROUND: 'nuclear respiratory factor 1' which has an official symbol of NRF1.
    [Show full text]
  • Human Small Maf Proteins Form Heterodimers with CNC Family Transcription Factors and Recognize the NF-E2 Motif
    Oncogene (1997) 14, 1901 ± 1910 1997 Stockton Press All rights reserved 0950 ± 9232/97 $12.00 Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif Tsutomu Toki1, Jugou Itoh2, Jun'ichi Kitazawa1, Koji Arai1, Koki Hatakeyama3, Jun-itsu Akasaka4, Kazuhiko Igarashi5, Nobuo Nomura6, Masaru Yokoyama1, Masayuki Yamamoto5 and Etsuro Ito1 1Department of Pediatrics, 2Medicine, School of Medicine; 3Department of Biology, Faculty of Sciences, Hirosaki University, Hirosaki 036; 4Department of Biochemistry, Tohoku University School of Medicine, Sendai 980-77; 5Center for TARA and Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba 305; 6Kazusa DNA Institute, Kisarazu 292, Japan The transcription factor NF-E2, a heterodimeric protein Talbot et al., 1990; Talbot and Grosveld, 1991; complex composed of p45 and small Maf family Kotkow and Orkin, 1995). Recent analyses demon- proteins, is considered crucial for the regulation of strated that NF-E2 is composed of two subunits erythroid gene expression and platelet formation. To (Andrews et al., 1993a,b; Igarashi et al., 1994). The facilitate the characterization of NF-E2 functions in large p45 subunit belongs to a family of basic leucine- human cells, we isolated cDNAs encoding two members zipper (bZip) proteins that is closely related to the of the small Maf family, MafK and MafG. The human Drosophila Cap`n'colar (the CNC family) factor mafK and mafG genes encode proteins of 156 and 162 (Mohler et al., 1991). It cannot bind to the NF-E2 amino acid residues, respectively, whose deduced amino sequence as a homodimer, but does do after forming acid sequences show approximately 95% identity to their heterodimers with chicken small Maf family proteins, respective chicken counterparts.
    [Show full text]
  • Supplementary Table 5. Clover Results Indicate the Number Of
    Supplementary Table 5. Clover results indicate the number of chromosomes with transcription factor binding motifs statistically over‐ or under‐represented in HTE DHS within intergenic sequence (more than 2kb outside of any gene). Analysis was divided into three groups (all DHS, HTE‐selective DHS, and ubiquitous DHS). Motifs with more than one entry in the databases utilized were edited to retain only the first occurrence of the motif. All DHS x Intergenic TE­selective DHS x Intergenic Ubiquitous DHS x Intergenic ID Name p < 0.01 p > 0.99 ID Name p < 0.01 p > 0.99 ID Name p < 0.01 p > 0.99 MA0002.2 RUNX1 23 0 MA0080.2 SPI1 23 0 MA0055.1 Myf 23 0 MA0003.1 TFAP2A 23 0 MA0089.1 NFE2L1::MafG 23 0 MA0068.1 Pax4 23 0 MA0039.2 Klf4 23 0 MA0098.1 ETS1 23 0 MA0080.2 SPI1 23 0 MA0055.1 Myf 23 0 MA0099.2 AP1 23 0 MA0098.1 ETS1 23 0 MA0056.1 MZF1_1‐4 23 0 MA0136.1 ELF5 23 0 MA0139.1 CTCF 23 0 MA0079.2 SP1 23 0 MA0145.1 Tcfcp2l1 23 0 V$ALX3_01 ALX‐3 23 0 MA0080.2 SPI1 23 0 MA0150.1 NFE2L2 23 0 V$ALX4_02 Alx‐4 23 0 myocyte enhancer MA0081.1 SPIB 23 0 MA0156.1 FEV 23 0 V$AMEF2_Q6 factor 23 0 MA0089.1 NFE2L1::MafG 23 0 V$AP1FJ_Q2 activator protein 1 23 0 V$AP1_01 AP‐1 23 0 MA0090.1 TEAD1 23 0 V$AP4_Q5 activator protein 4 23 0 V$AP2_Q6_01 AP‐2 23 0 MA0098.1 ETS1 23 0 V$AR_Q6 half‐site matrix 23 0 V$ARX_01 Arx 23 0 BTB and CNC homolog MA0099.2 AP1 23 0 V$BACH1_01 1 23 0 V$BARHL1_01 Barhl‐1 23 0 BTB and CNC homolog MA0136.1 ELF5 23 0 V$BACH2_01 2 23 0 V$BARHL2_01 Barhl2 23 0 MA0139.1 CTCF 23 0 V$CMAF_02 C‐MAF 23 0 V$BARX1_01 Barx1 23 0 MA0144.1 Stat3 23 0
    [Show full text]
  • Reprogramming of Lysosomal Gene Expression by Interleukin-4 and Stat6 Brignull Et Al
    Reprogramming of lysosomal gene expression by interleukin-4 and Stat6 Brignull et al. Brignull et al. BMC Genomics 2013, 14:853 http://www.biomedcentral.com/1471-2164/14/853 Brignull et al. BMC Genomics 2013, 14:853 http://www.biomedcentral.com/1471-2164/14/853 RESEARCH ARTICLE Open Access Reprogramming of lysosomal gene expression by interleukin-4 and Stat6 Louise M Brignull1†, Zsolt Czimmerer2†, Hafida Saidi1,3, Bence Daniel2, Izabel Villela4,5, Nathan W Bartlett6, Sebastian L Johnston6, Lisiane B Meira4, Laszlo Nagy2,7 and Axel Nohturfft1* Abstract Background: Lysosomes play important roles in multiple aspects of physiology, but the problem of how the transcription of lysosomal genes is coordinated remains incompletely understood. The goal of this study was to illuminate the physiological contexts in which lysosomal genes are coordinately regulated and to identify transcription factors involved in this control. Results: As transcription factors and their target genes are often co-regulated, we performed meta-analyses of array-based expression data to identify regulators whose mRNA profiles are highly correlated with those of a core set of lysosomal genes. Among the ~50 transcription factors that rank highest by this measure, 65% are involved in differentiation or development, and 22% have been implicated in interferon signaling. The most strongly correlated candidate was Stat6, a factor commonly activated by interleukin-4 (IL-4) or IL-13. Publicly available chromatin immunoprecipitation (ChIP) data from alternatively activated mouse macrophages show that lysosomal genes are overrepresented among Stat6-bound targets. Quantification of RNA from wild-type and Stat6-deficient cells indicates that Stat6 promotes the expression of over 100 lysosomal genes, including hydrolases, subunits of the vacuolar H+ ATPase and trafficking factors.
    [Show full text]
  • Identification of Dna Sequence Variants in the Estrogen
    IDENTIFICATION OF DNA SEQUENCE VARIANTS IN THE ESTROGEN RECEPTOR PATHWAY IN BREAST CANCER by Seyed Amir Bahreini BSc in Cell & Mol Biology, University of Isfahan, Iran, 2010 Submitted to the Graduate Faculty of Department of Human Genetics Graduate School of Public Health in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2016 UNIVERSITY OF PITTSBURGH Graduate School of Public Health This dissertation was presented by Seyed Amir Bahreini It was defended on April 6, 2016 and approved by Dissertation Advisor: Steffi Oesterreich, PhD Professor Department of Pharmacology and Chemical Biology School of Medicine University of Pittsburgh Committee Members: Candace M. Kammerer, PhD Professor Department of Human Genetics Graduate School of Public Health University of Pittsburgh Adrian V. Lee, PhD Professor Department of Pharmacology and Chemical Biology School of Medicine University of Pittsburgh Ryan L. Minster, PhD Professor Department of Human Genetics Graduate School of Public Health University of Pittsburgh ii Copyright © by Seyed Amir Bahreini 2016 iii Steffi Oesterreich, PhD IDENTIFICATION OF DNA SEQUENCE VARIANTS IN THE ESTROGEN RECEPTOR PATHWAY IN BREAST CANCER Seyed Amir Bahreini, PhD University of Pittsburgh, 2016 ABSTRACT Breast cancer is of public health importance with an increasing incidence over the past decade. Estrogen Receptor (ER) activity is critical for promoting majority of breast cancers. Inhibiting ER is one of the most successful targeted therapies in oncology. Studies have suggested that genomic variation in ER binding sites and ESR1 gene may be responsible for endocrine treatment response and cancer progression. We investigated the role of single nucleotide variants (SNVs) in the ER pathway in breast cancer, including clinically relevant mutations in ER gene and regulatory variants in ER binding sites.
    [Show full text]
  • Nfe2l1) As a Hypoxia- Inducible Factor and Its Oxygen-Dependent Regulation in Vitro and in Vivo
    IDENTIFICATION OF NRFl (NFE2L1) AS A HYPOXIA- INDUCIBLE FACTOR AND ITS OXYGEN-DEPENDENT REGULATION IN VITRO AND IN VIVO by NIKOLAI L. CHEPELEV B. Sc. H. Carleton University, 2006 A thesis submitted to the Faculty of Graduate and Postdoctoral Affairs in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biology Department of Biology Ottawa-Carleton Institute of Biology Carleton University Ottawa, Ontario, Canada September 2011 © 2011 Nikolai Chepelev Library and Archives Bibliotheque et 1*1 Canada Archives Canada Published Heritage Direction du Branch Patrimoine de I'edition 395 Wellington Street 395, rue Wellington OttawaONK1A0N4 OttawaONK1A0N4 Canada Canada Your file Votre rdterence ISBN: 978-0-494-83249-3 Our file Notre reference ISBN: 978-0-494-83249-3 NOTICE: AVIS: The author has granted a non­ L'auteur a accorde une licence non exclusive exclusive license allowing Library and permettant a la Bibliotheque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par telecommunication ou par I'lnternet, prefer, telecommunication or on the Internet, distribuer et vendre des theses partout dans le loan, distribute and sell theses monde, a des fins commerciales ou autres, sur worldwide, for commercial or non­ support microforme, papier, electronique et/ou commercial purposes, in microform, autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriete du droit d'auteur ownership and moral rights in this et des droits moraux qui protege cette these. Ni thesis. Neither the thesis nor la these ni des extraits substantiels de celle-ci substantial extracts from it may be ne doivent etre imprimes ou autrement printed or otherwise reproduced reproduits sans son autorisation.
    [Show full text]
  • Metabolic Profiling of Cancer Cells Reveals Genome-Wide
    ARTICLE https://doi.org/10.1038/s41467-019-09695-9 OPEN Metabolic profiling of cancer cells reveals genome- wide crosstalk between transcriptional regulators and metabolism Karin Ortmayr 1, Sébastien Dubuis1 & Mattia Zampieri 1 Transcriptional reprogramming of cellular metabolism is a hallmark of cancer. However, systematic approaches to study the role of transcriptional regulators (TRs) in mediating 1234567890():,; cancer metabolic rewiring are missing. Here, we chart a genome-scale map of TR-metabolite associations in human cells using a combined computational-experimental framework for large-scale metabolic profiling of adherent cell lines. By integrating intracellular metabolic profiles of 54 cancer cell lines with transcriptomic and proteomic data, we unraveled a large space of associations between TRs and metabolic pathways. We found a global regulatory signature coordinating glucose- and one-carbon metabolism, suggesting that regulation of carbon metabolism in cancer may be more diverse and flexible than previously appreciated. Here, we demonstrate how this TR-metabolite map can serve as a resource to predict TRs potentially responsible for metabolic transformation in patient-derived tumor samples, opening new opportunities in understanding disease etiology, selecting therapeutic treat- ments and in designing modulators of cancer-related TRs. 1 Institute of Molecular Systems Biology, ETH Zurich, Otto-Stern-Weg 3, CH-8093 Zurich, Switzerland. Correspondence and requests for materials should be addressed to M.Z. (email: [email protected]) NATURE COMMUNICATIONS | (2019) 10:1841 | https://doi.org/10.1038/s41467-019-09695-9 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09695-9 ranscriptional regulators (TRs) are at the interface between implemented by the additional quantification of total protein the cell’s ability to sense and respond to external stimuli or abundance and is based on the assumption that protein content T 1 changes in internal cell-state .
    [Show full text]